FGF23 is a biomarker for osteoporosis and cardiovascular calcification.
Calibrated: The glycosylated human FGF23 (25-251) recombinant
Citations:
Anne-Sophie Bargnoux et al. "Biomarkers of vascular calcifications: what are analytical limits to apply “research-grade” diagnostic kits into daily practice?" doi: 10.1684/abc.2015.1043.
Muhammed Kizilgu, et al. "Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?" Arch Endocrinol Metab. 2017 Dec;61(6):562-566. doi: 10.1590/2359-3997000000287
Size: 2 x 96 T
Standard Range: 31.25-2000 pg/ml
Sensitivity: 15 pg/ml Calibrator: Human FGF23 Mature Form (25-251)
Sample Type: cell culture, serum, EDTA plasma
Sample Required: 100uL of diluted samples per well
